Immunocore Holdings (IMCR) Selling, General & Administrative (2021 - 2026)
Immunocore Holdings (IMCR) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Immunocore Holdings | 1.77 Bn | 925.68 Mn | 106.24 Mn | 37.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.85 Mn |
| Dec 31, 2025 | 42.65 Mn |
| Sep 30, 2025 | 39.78 Mn |
| Jun 30, 2025 | 42.79 Mn |
| Mar 31, 2025 | 40.20 Mn |
| Dec 31, 2024 | 42.32 Mn |
| Sep 30, 2024 | 35.53 Mn |
| Jun 30, 2024 | 38.64 Mn |
| Mar 31, 2024 | 39.29 Mn |
| Dec 31, 2023 | 41.45 Mn |
| Sep 30, 2023 | 35.47 Mn |
| Jun 30, 2023 | 42.40 Mn |
| Mar 31, 2023 | 32.57 Mn |
| Dec 31, 2022 | 50.60 Mn |
| Sep 30, 2022 | 13.75 Mn |
| Jun 30, 2022 | 25.32 Mn |
| Dec 31, 2021 | 32.85 Mn |
| Sep 30, 2021 | 27.64 Mn |